NR1H3 and atherosclerosis: Recent studies have found that LXRα activation can enhance the prognosis of patients with inflammatory diseases, including atherosclerosis, Alzheimer's disease, and nonalcoholic fatty liver, by inducing anti-inflammatory effects (Che et al. 2021; Dib et al. 2023; Huang et al. 2018).